Test Price
2,800 AED✅ Home Collection Available
SCN9A Gene Sequencing for Insensitivity to Pain (Channelopathy-Associated) – Genetic Test in UAE | AED 2,800 | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available Daily from 8 AM to 11 PM)
- Clinical Guidance: Post-Test Genetic Counseling and Result Interpretation by a Consultant Medical Geneticist
- Insurance: Direct Billing Verification & Eligibility Check via WhatsApp +971 54 548 8731
Test Overview & Methodology
The SCN9A gene sequencing test screens for mutations in the SCN9A gene responsible for congenital insensitivity to pain (CIP) and related channelopathies. Our Next-Generation Sequencing (NGS) assay provides comprehensive coverage of the coding regions and splice sites, delivering a highly accurate molecular diagnosis to guide clinical management, safety planning, and genetic counseling.
| Feature | Our Test – NGS | Closest Alternative – Sanger Sequencing |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Sanger sequencing – targeted hotspots only |
| Diagnostic Sensitivity | 99.9% | ~85% |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Variant Detection | SNVs, Indels, Copy Number Variations | Only Known Point Mutations |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I advise that the SCN9A sequencing report is a critical tool for diagnosing hereditary pain insensitivity syndromes. Genetic results must be interpreted within the full clinical phenotype, family history, and neurological evaluation. A negative result does not exclude a genetic etiology, and variants of uncertain significance require careful segregation analysis. Our comprehensive post-test counseling ensures that patients and families understand the implications for surveillance, safety, and preventive care."
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Clinical Management
Do not discontinue, alter, or initiate any prescribed medication or therapy without the direct oversight of your treating physician. Genetic test results are one component of a holistic diagnostic workup.
Exclusion Criteria & Emergency Red Flags
- Exclusions: Active bleeding disorders, acute infection at the phlebotomy site, and pregnancy (requires obstetric clearance before sampling).
- Emergency Red Flags: If you or a family member experiences sudden paralysis, loss of bladder or bowel control, altered consciousness, or unexplained severe pain, seek emergency medical attention immediately. Do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the SCN9A gene test and why is it important?
The SCN9A gene test identifies mutations causing congenital insensitivity to pain (CIP) and channelopathy-associated pain disorders, enabling precise diagnosis and tailored preventive care. This test is essential for individuals with a history of unexplained painlessness, recurrent fractures, burns, or suspected hereditary sensory neuropathies. Early molecular confirmation supports specialized clinical surveillance, injury prevention strategies, and informed genetic counseling for at-risk family members.
2. How is the sample collected and what is the turnaround time?
A standard peripheral whole blood sample or FTA card specimen is collected by a VIP Mobile Phlebotomist at your home, with results available within 3–4 weeks. We offer hospital-grade, temperature-controlled cold-chain home collection across all Emirates, available daily from 8 AM to 11 PM. Samples are transported under strict chain-of-custody protocols to our ISO 9001:2015 certified laboratory. A pre-test genetic counseling session is recommended to review family history and discuss the implications of possible results.
3. Is this test covered by insurance in the UAE?
Many UAE health insurers cover medically indicated genetic testing; we verify your coverage and obtain direct approval before scheduling your appointment. Our dedicated billing team confirms eligibility with your provider under DHA and MOHAP regulations. Your genetic data is handled with the highest privacy standards in full compliance with UAE data protection laws. Contact us via WhatsApp at +971 54 548 8731 for a rapid insurance eligibility check.
UAE Regulatory & Data Privacy Adherence
- Data Protection: Your genetic and personal data are processed under strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Governance: We adhere to Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields, ensuring secure storage and transmission of all health records.
- Clinical Safety & Consent: All clinical testing and patient consent procedures follow the standards set forth in Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and legal compliance.
- Accreditation: Our laboratory holds ISO 9001:2015 certification and operates under the regulatory oversight of the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | SCN9A Gene Sequencing for Insensitivity to Pain (Channelopathy-Associated) – NGS |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or FTA Card (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | G60.8 (Other Hereditary and Idiopathic Neuropathies) |
| LOINC Code | 82939-0 (SCN9A gene mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Address | DNA Labs UAE | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians